Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1693)
Pharvaris N.V. (PHVS)
Monges Viviane — Director
Shares
11,969
Price
$33.05
Total Value
$395.52K
Shares Held After
5,500
% of Holdings
68.5%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
49,036
Price
$2.69
Total Value
$131.91K
Shares Held After
1,046,003
% of Holdings
4.7%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
7,401
Price
$21.03
Total Value
$155.65K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
5,099
Price
$20.19
Total Value
$102.97K
Shares Held After
7,401
% of Holdings
40.8%
AtriCure, Inc. (ATRC)
Privitera Salvatore — Chief Technical Officer
Shares
4,519
Price
$60.00
Total Value
$271.14K
Shares Held After
142,745
% of Holdings
3.1%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$20.95
Total Value
$209.50K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$500.05
Total Value
$120.01K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
90
Price
$498.90
Total Value
$44.90K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
270
Price
$498.38
Total Value
$134.56K
Shares Held After
324,773
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
766
Price
$497.27
Total Value
$380.91K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
525
Price
$496.38
Total Value
$260.60K
Shares Held After
325,809
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
155
Price
$495.17
Total Value
$76.75K
Shares Held After
326,334
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$493.72
Total Value
$79.00K
Shares Held After
326,489
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$492.54
Total Value
$236.42K
Shares Held After
326,649
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$491.65
Total Value
$405.12K
Shares Held After
327,129
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,440
Price
$490.48
Total Value
$706.29K
Shares Held After
327,953
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,162
Price
$489.52
Total Value
$1.06M
Shares Held After
329,393
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,388
Price
$488.70
Total Value
$1.17M
Shares Held After
331,555
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
4,528
Price
$1.61
Total Value
$7.29K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
114,851
Price
$1.61
Total Value
$184.91K
Shares Held After
0
% of Holdings
100.0%
Butterfly Network, Inc. (BFLY)
DEVIVO JOSEPH — Director
Shares
3,169
Price
$10.02
Total Value
$31.76K
Shares Held After
7,347,720
% of Holdings
0.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
4,528
Price
$1.61
Total Value
$7.29K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
114,851
Price
$1.61
Total Value
$184.91K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
43
Price
$41.05
Total Value
$1.77K
Shares Held After
456,767
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
215
Price
$39.86
Total Value
$8.57K
Shares Held After
456,810
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
1,952
Price
$39.05
Total Value
$76.23K
Shares Held After
457,025
% of Holdings
0.4%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
30,000
Price
$99.40
Total Value
$2.98M
Shares Held After
380,209
% of Holdings
7.3%
111, Inc. (YI)
Chen Yang Luke — Director
Shares
44,000
Price
$0.18
Total Value
$7.92K
Shares Held After
451,462
% of Holdings
8.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,900
Price
$1.05
Total Value
$2.00K
Shares Held After
383,885
% of Holdings
0.5%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,318
Price
$2.10
Total Value
$11.17K
Shares Held After
2,855,318
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$100.00
Total Value
$500.00K
Shares Held After
434,360
% of Holdings
1.2%
Mineralys Therapeutics, Inc. (MLYS)
Slingsby Brian Taylor — Director
Shares
104,320
Price
$28.81
Total Value
$3.01M
Shares Held After
7,805,718
% of Holdings
1.3%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$20.95
Total Value
$209.50K
Shares Held After
0
% of Holdings
100.0%
IMPACT BIOMEDICAL INC. (IBO)
DSS, INC. — 10% Owner
Shares
723
Price
$0.55
Total Value
$397.65
Shares Held After
589,701
% of Holdings
0.1%
10x Genomics, Inc. (TXG)
SULIMAN SHEHNAAZ — Director
Shares
1,222
Price
$82.28
Total Value
$100.54K
Shares Held After
23,792
% of Holdings
4.9%
10x Genomics, Inc. (TXG)
SULIMAN SHEHNAAZ — Director
Shares
2,270
Price
$81.67
Total Value
$185.39K
Shares Held After
25,014
% of Holdings
8.3%
10x Genomics, Inc. (TXG)
SULIMAN SHEHNAAZ — Director
Shares
1,325
Price
$80.82
Total Value
$107.08K
Shares Held After
27,284
% of Holdings
4.6%
10x Genomics, Inc. (TXG)
SULIMAN SHEHNAAZ — Director
Shares
614
Price
$79.51
Total Value
$48.82K
Shares Held After
28,609
% of Holdings
2.1%
10x Genomics, Inc. (TXG)
SULIMAN SHEHNAAZ — Director
Shares
292
Price
$78.20
Total Value
$22.83K
Shares Held After
29,223
% of Holdings
1.0%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
10,400
Price
$60.24
Total Value
$626.46K
Shares Held After
94,784
% of Holdings
9.9%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,088
Price
$1.65
Total Value
$1.80K
Shares Held After
4,528
% of Holdings
19.4%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
27,612
Price
$1.65
Total Value
$45.56K
Shares Held After
114,851
% of Holdings
19.4%
Butterfly Network, Inc. (BFLY)
DEVIVO JOSEPH — Director
Shares
2,811
Price
$10.00
Total Value
$28.11K
Shares Held After
7,350,889
% of Holdings
0.0%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
100
Price
$195.15
Total Value
$19.52K
Shares Held After
4,333
% of Holdings
2.3%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
1,500
Price
$194.59
Total Value
$291.88K
Shares Held After
4,433
% of Holdings
25.3%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
2,648
Price
$193.44
Total Value
$512.23K
Shares Held After
5,933
% of Holdings
30.9%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
4,985
Price
$192.54
Total Value
$959.81K
Shares Held After
8,581
% of Holdings
36.7%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
910
Price
$191.85
Total Value
$174.59K
Shares Held After
13,566
% of Holdings
6.3%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
160
Price
$78.86
Total Value
$12.62K
Shares Held After
100,000
% of Holdings
0.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
14,042
Price
$78.23
Total Value
$1.10M
Shares Held After
100,160
% of Holdings
12.3%
Showing 51–100 of 1693 transactions (page 2 of 34)